| Medical and Health Sciences | Lifetime | 101 | GB 12 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 100 | GB 11 | 99.98 |
| Health Information Management | Lifetime | 2 | GB 1 | 99.97 |
| General Health Professions | Lifetime | 117 | GB 19 | 99.85 |
| Immunology and Allergy | Lifetime | 15 | GB 1 | 99.74 |
| Medical Physiology | Lifetime | 134 | GB 14 | 99.80 |
| Public, Environmental and Occupational Health | Lifetime | 215 | GB 31 | 99.70 |
| Emergency Medical Services | Lifetime | 68 | GB 8 | 99.14 |
| Pulmonary and Respiratory Medicine | Lifetime | 776 | GB 53 | 98.82 |
| Health | Lifetime | 280 | GB 38 | 98.24 |
| Organizational Behavior and Human Resource Management | Lifetime | 710 | GB 89 | 97.89 |
| Pharmacy | Lifetime | 283 | GB 28 | 96.48 |
| Infectious Diseases | Lifetime | 886 | GB 73 | 95.68 |
| Geriatrics and Gerontology | Lifetime | 228 | GB 23 | 94.43 |
| Dermatology | Lifetime | 613 | GB 55 | 94.60 |
| Ophthalmology | Lifetime | 752 | GB 71 | 82.03 |
| Infectious Diseases | 2021-2025 | 43 | GB 5 | 99.45 |
| Health Information Management | 2021-2025 | 32 | GB 1 | 97.73 |
| General Health Professions | 2021-2025 | 263 | GB 33 | 98.16 |
| Medical Physiology | 2021-2025 | 231 | GB 27 | 96.92 |
| Health | 2021-2025 | 169 | GB 29 | 95.33 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 439 | GB 28 | 95.32 |
| Epidemiology | 2021-2025 | 725 | GB 66 | 92.87 |
| Oncology | 2021-2025 | 545 | GB 23 | 92.32 |
| Clinical Neurology | 2021-2025 | 309 | GB 33 | 90.48 |
| Public, Environmental and Occupational Health | 2021-2025 | 960 | GB 98 | 90.02 |
| Immunology and Allergy | 2021-2025 | 147 | GB 11 | 85.60 |
| Asthma and respiratory diseases | Lifetime | 14 | GB 5 | 99.92 |
| Electronic Health Records Systems | Lifetime | 2 | GB 1 | 99.88 |
| Healthcare Systems and Technology | Lifetime | 4 | GB 2 | 99.88 |
| Allergic Rhinitis and Sensitization | Lifetime | 20 | GB 4 | 99.85 |
| Food Allergy and Anaphylaxis Research | Lifetime | 12 | GB 1 | 99.83 |
| Telemedicine and Telehealth Implementation | Lifetime | 5 | GB 2 | 99.57 |
| Medical Coding and Health Information | Lifetime | 2 | GB 1 | 99.58 |
| COVID-19 and healthcare impacts | Lifetime | 30 | GB 6 | 99.09 |
| COVID-19 Clinical Research Studies | Lifetime | 135 | GB 14 | 99.22 |
| Long-Term Effects of COVID-19 | Lifetime | 106 | GB 22 | 98.77 |
| Mobile Health and mHealth Applications | Lifetime | 53 | GB 7 | 99.18 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 195 | GB 15 | 99.17 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 141 | GB 23 | 99.35 |
| Drug-Induced Adverse Reactions | Lifetime | 37 | GB 3 | 98.99 |
| Eosinophilic Esophagitis | Lifetime | 112 | GB 6 | 99.28 |
| Patient Safety and Medication Errors | Lifetime | 43 | GB 11 | 99.11 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 110 | GB 13 | 98.69 |
| Primary Care and Health Outcomes | Lifetime | 137 | GB 25 | 98.93 |
| Chronic Disease Management Strategies | Lifetime | 147 | GB 32 | 98.71 |
| Delphi Technique in Research | Lifetime | 51 | GB 14 | 98.55 |
| Health Literacy and Information Accessibility | Lifetime | 69 | GB 8 | 97.94 |
| Respiratory and Cough-Related Research | Lifetime | 174 | GB 33 | 98.88 |
| Dermatology and Skin Diseases | Lifetime | 269 | GB 30 | 98.57 |
| Palliative Care and End-of-Life Issues | Lifetime | 389 | GB 43 | 98.14 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 751 | GB 123 | 98.30 |
| Ethics in Clinical Research | Lifetime | 138 | GB 23 | 96.88 |
| Medical Malpractice and Liability Issues | Lifetime | 159 | GB 21 | 97.06 |
| COVID-19 and Mental Health | Lifetime | 523 | GB 77 | 96.42 |
| Smoking Behavior and Cessation | Lifetime | 344 | GB 33 | 97.01 |
| Vaccine Coverage and Hesitancy | Lifetime | 497 | GB 45 | 96.77 |
| Artificial Intelligence in Healthcare | Lifetime | 225 | GB 10 | 94.71 |
| Machine Learning in Healthcare | Lifetime | 173 | GB 17 | 94.95 |
| Quality and Safety in Healthcare | Lifetime | 134 | GB 21 | 95.81 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 196 | GB 43 | 95.97 |
| Health Policy Implementation Science | Lifetime | 493 | GB 80 | 95.91 |
| Grief, Bereavement, and Mental Health | Lifetime | 411 | GB 55 | 95.74 |
| Health, psychology, and well-being | Lifetime | 379 | GB 80 | 95.53 |
| Contact Dermatitis and Allergies | Lifetime | 528 | GB 43 | 95.90 |
| Patient Satisfaction in Healthcare | Lifetime | 477 | GB 62 | 95.40 |
| COVID-19 epidemiological studies | Lifetime | 906 | GB 113 | 95.01 |
| Pediatric health and respiratory diseases | Lifetime | 920 | GB 102 | 94.70 |
| Religion, Spirituality, and Psychology | Lifetime | 372 | GB 41 | 94.71 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 378 | GB 39 | 92.55 |
| Healthcare Quality and Management | Lifetime | 204 | GB 58 | 94.12 |
| Healthcare cost, quality, practices | Lifetime | 527 | GB 84 | 94.04 |
| Global Public Health Policies and Epidemiology | Lifetime | 711 | GB 111 | 93.32 |
| Diabetes Management and Education | Lifetime | 703 | GB 71 | 94.17 |
| School Health and Nursing Education | Lifetime | 442 | GB 44 | 93.53 |
| Health and Medical Research Impacts | Lifetime | 478 | GB 55 | 91.76 |
| Urticaria and Related Conditions | Lifetime | 815 | GB 49 | 94.13 |
| Patient-Provider Communication in Healthcare | Lifetime | 790 | GB 110 | 93.81 |
| Clinical practice guidelines implementation | Lifetime | 915 | GB 166 | 92.05 |
| COVID-19 Impact on Reproduction | Lifetime | 573 | GB 42 | 90.19 |
| Dietary Effects on Health | Lifetime | 500 | GB 55 | 92.14 |
| Ocular Infections and Treatments | Lifetime | 714 | GB 49 | 93.04 |
| Clinical Reasoning and Diagnostic Skills | Lifetime | 675 | GB 64 | 90.56 |
| Medical Research and Practices | Lifetime | 47 | GB 6 | 85.67 |
| Biomedical and Engineering Education | Lifetime | 755 | GB 36 | 85.32 |
| Travel-related health issues | Lifetime | 710 | GB 79 | 82.32 |
| Healthcare Technology and Patient Monitoring | Lifetime | 726 | GB 57 | 83.28 |
| Healthcare Systems and Challenges | Lifetime | 677 | GB 291 | 67.87 |
| COVID-19 and healthcare impacts | 2021-2025 | 11 | GB 5 | 99.36 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 60 | GB 5 | 99.65 |
| COVID-19 Clinical Research Studies | 2021-2025 | 73 | GB 8 | 99.52 |
| Long-Term Effects of COVID-19 | 2021-2025 | 52 | GB 16 | 99.12 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 36 | GB 9 | 99.21 |
| Asthma and respiratory diseases | 2021-2025 | 105 | GB 15 | 98.92 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 137 | GB 13 | 97.45 |
| Electronic Health Records Systems | 2021-2025 | 25 | GB 3 | 96.52 |
| Telemedicine and Telehealth Implementation | 2021-2025 | 148 | GB 15 | 92.99 |
| COVID-19 Impact on Reproduction | 2021-2025 | 228 | GB 19 | 92.90 |
| COVID-19 and Mental Health | 2021-2025 | 894 | GB 106 | 93.41 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 273 | GB 32 | 92.80 |
| Climate Change and Health Impacts | 2021-2025 | 542 | GB 37 | 92.12 |
| Healthcare Systems and Technology | 2021-2025 | 65 | GB 13 | 91.05 |
| Chronic Disease Management Strategies | 2021-2025 | 576 | GB 122 | 88.21 |
| Influenza Virus Research Studies | 2021-2025 | 632 | GB 42 | 88.55 |
| Antibiotic Use and Resistance | 2021-2025 | 735 | GB 76 | 87.98 |
| Patient Satisfaction in Healthcare | 2021-2025 | 385 | GB 26 | 82.06 |
| Data-Driven Disease Surveillance | 2021-2025 | 221 | GB 24 | 80.95 |
| Global Health Care Issues | 2021-2025 | 768 | GB 90 | 80.05 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 652 | GB 26 | 81.13 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 269 | GB 27 | 77.86 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 807 | GB 36 | 82.05 |
| Respiratory and Cough-Related Research | 2021-2025 | 709 | GB 85 | 79.97 |
| Primary Care and Health Outcomes | 2021-2025 | 932 | GB 106 | 77.90 |
| Machine Learning in Healthcare | 2021-2025 | 831 | GB 68 | 76.55 |
| School Health and Nursing Education | 2021-2025 | 402 | GB 32 | 67.34 |
| Delphi Technique in Research | 2021-2025 | 916 | GB 240 | 64.70 |
| Patient Safety and Medication Errors | 2021-2025 | 832 | GB 57 | 64.88 |
| Healthcare Systems and Challenges | 2021-2025 | 138 | GB 47 | 61.52 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 987 | GB 123 | 42.18 |
| Travel-related health issues | 2021-2025 | 986 | GB 40 | 23.46 |